The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

BACKGROUND: The nature and rate of gastric mucosal (GM) damage in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) remain to be among the unsolved problems. OBJECTIVE: To define the role of H. pylori and drugs in the development of GM damages in SLE and APS. METHODS: A study wa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Rheumatol
Main Authors: Reshetnyak, Tatiana M., Doroshkevich, Irina A., Seredavkina, Natalia V., Nasonov, Evgeny L., Maev, Igor V., Reshetnyak, Vasiliy I.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525898/
https://ncbi.nlm.nih.gov/pubmed/31191660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9698086
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares